BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6129576)

  • 1. [40 years of salazosulfapyridine. Is end in sight?].
    van Hees PA; van Tongeren JH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2014-8. PubMed ID: 6129576
    [No Abstract]   [Full Text] [Related]  

  • 2. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H; Kruis W
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine].
    Bures J; Horácek J; Tilser P; Fixa B; Komárková O; Tichý M; Zaydlar K; Král B
    Cas Lek Cesk; 1986 Jul; 125(29):905-9. PubMed ID: 2873894
    [No Abstract]   [Full Text] [Related]  

  • 4. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
    Feurle GE; Helmstädter V
    Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possible mechanism of action of Azulfidine/Salazopyrin].
    Campbell DE
    Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of the colon in the metabolism of salicylazosulphapyridine.
    Das KM; Eastwood MA; McManus JP; Sircus W
    Scand J Gastroenterol; 1974; 9(2):137-41. PubMed ID: 4150441
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT
    N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
    [No Abstract]   [Full Text] [Related]  

  • 9. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
    Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1987 Apr; 11(4):325-32. PubMed ID: 2884162
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).
    Franklin JL; Rosenberg HH
    Gastroenterology; 1973 Apr; 64(4):517-25. PubMed ID: 4144775
    [No Abstract]   [Full Text] [Related]  

  • 12. [Exacerbation of ulcerative colitis and Crohn disease as a phenomenon inherent in the disease].
    Habs M; Schifmann R
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1131. PubMed ID: 2874004
    [No Abstract]   [Full Text] [Related]  

  • 13. [Azulfidine/Salazopyrin therapy during pregnancy].
    Fahrländer H
    Z Gastroenterol Verh; 1981 Jun; 19():24-6. PubMed ID: 6168128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE
    Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J; Mott CB; Machado MC
    Int Surg; 1985; 70(3):271-2. PubMed ID: 2872181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Salazosulfapyridine-induced exacerbation of ulcerative colitis].
    Dominick HC; Müller KM; Mensing E
    Monatsschr Kinderheilkd; 1985 May; 133(5):304-6. PubMed ID: 2861562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug information. Pentasa--new Danish drug].
    Dahlerup J
    Sygeplejersken; 1988 Jul; 88(28):16. PubMed ID: 2902698
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
    Eitner K; Hippius M; Reinicke C
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):14-9. PubMed ID: 6122556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfasalazine: I. An historical perspective.
    Bachrach WH
    Am J Gastroenterol; 1988 May; 83(5):487-96. PubMed ID: 2896458
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of salazopyrin on water and electrolyte transport in the human colon measured in vivo and in vitro.
    Harris J; Archampong EQ; Clark CG
    Gut; 1972 Oct; 13(10):855. PubMed ID: 4404481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.